Pacira BioSciences (PCRX) Competitors

Pacira BioSciences (NASDAQ:PCRX) and Perrigo (NYSE:PRGO) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, community ranking, earnings, valuation and media sentiment.

Do insiders & institutionals have more ownership in PCRX or PRGO?

99.7% of Pacira BioSciences shares are held by institutional investors. Comparatively, 95.9% of Perrigo shares are held by institutional investors. 6.4% of Pacira BioSciences shares are held by insiders. Comparatively, 0.7% of Perrigo shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Does the media refer more to PCRX or PRGO?

In the previous week, Pacira BioSciences had 4 more articles in the media than Perrigo. MarketBeat recorded 11 mentions for Pacira BioSciences and 7 mentions for Perrigo. Pacira BioSciences' average media sentiment score of 1.29 beat Perrigo's score of 0.65 indicating that Pacira BioSciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pacira BioSciences	5 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Perrigo	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility and risk, PCRX or PRGO?

Pacira BioSciences has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500. Comparatively, Perrigo has a beta of 0.48, indicating that its stock price is 52% less volatile than the S&P 500.

Is PCRX or PRGO more profitable?

Perrigo has a net margin of -3.64% compared to Pacira BioSciences' net margin of -13.07%. Pacira BioSciences' return on equity of 13.42% beat Perrigo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pacira BioSciences	-13.07%	13.42%	7.19%
Perrigo	-3.64%	7.38%	3.18%

Does the MarketBeat Community favor PCRX or PRGO?

Pacira BioSciences received 57 more outperform votes than Perrigo when rated by MarketBeat users. Likewise, 71.50% of users gave Pacira BioSciences an outperform vote while only 66.35% of users gave Perrigo an outperform vote.

Company	Underperform	Outperform
Pacira BioSciences	Outperform Votes 828 71.50%	Underperform Votes 330 28.50%
Perrigo	Outperform Votes 771 66.35%	Underperform Votes 391 33.65%

Do analysts recommend PCRX or PRGO?

Pacira BioSciences presently has a consensus price target of $27.22, suggesting a potential upside of 7.60%. Perrigo has a consensus price target of $33.00, suggesting a potential upside of 18.97%. Given Perrigo's higher probable upside, analysts plainly believe Perrigo is more favorable than Pacira BioSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pacira BioSciences	1 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.33
Perrigo	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25

Which has stronger earnings & valuation, PCRX or PRGO?

Pacira BioSciences has higher earnings, but lower revenue than Perrigo. Perrigo is trading at a lower price-to-earnings ratio than Pacira BioSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pacira BioSciences	$700.97M	1.67	$41.96M	-$2.19	-11.55
Perrigo	$4.37B	0.87	-$12.70M	-$1.25	-22.19

Summary

Pacira BioSciences beats Perrigo on 14 of the 18 factors compared between the two stocks.